Cryo-Cell International I... (CCEL)
Cryo-Cell International Statistics
Share Statistics
Cryo-Cell International has 8.08M shares outstanding. The number of shares has increased by -2.71% in one year.
| Shares Outstanding | 8.08M |
| Shares Change (YoY) | -2.71% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 12.79% |
| Shares Floating | 4.43M |
| Failed to Deliver (FTD) Shares | 2 |
| FTD / Avg. Volume | 0.01% |
Short Selling Information
The latest short interest is 15.67K, so 0.19% of the outstanding shares have been sold short.
| Short Interest | 15.67K |
| Short % of Shares Out | 0.19% |
| Short % of Float | 0.41% |
| Short Ratio (days to cover) | 1.13 |
Valuation Ratios
The PE ratio is 175.31 and the forward PE ratio is 62.33. Cryo-Cell International's PEG ratio is -1.12.
| PE Ratio | 175.31 |
| Forward PE | 62.33 |
| PS Ratio | 2.2 |
| Forward PS | 1.6 |
| PB Ratio | -5.33 |
| P/FCF Ratio | 19.54 |
| PEG Ratio | -1.12 |
Enterprise Valuation
Cryo-Cell International Inc. has an Enterprise Value (EV) of 55.11M.
| EV / Earnings | 137.07 |
| EV / Sales | 1.72 |
| EV / EBITDA | 38.73 |
| EV / EBIT | 15.84 |
| EV / FCF | 15.28 |
Financial Position
The company has a current ratio of 0.58, with a Debt / Equity ratio of -0.34.
| Current Ratio | 0.58 |
| Quick Ratio | 0.55 |
| Debt / Equity | -0.34 |
| Total Debt / Capitalization | -50.82 |
| Cash Flow / Debt | 1.35 |
| Interest Coverage | 1.87 |
Financial Efficiency
Return on equity (ROE) is -0.03% and return on capital (ROIC) is -5.7%.
| Return on Equity (ROE) | -0.03% |
| Return on Assets (ROA) | 0.01% |
| Return on Capital (ROIC) | -5.7% |
| Revenue Per Employee | $390,074.46 |
| Profits Per Employee | $4,903.6 |
| Employee Count | 82 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 12.08 |
Taxes
| Income Tax | 2.4M |
| Effective Tax Rate | 0.86 |
Stock Price Statistics
The stock price has increased by -6.09% in the last 52 weeks. The beta is 0.64, so Cryo-Cell International's price volatility has been higher than the market average.
| Beta | 0.64 |
| 52-Week Price Change | -6.09% |
| 50-Day Moving Average | 7.32 |
| 200-Day Moving Average | 7.35 |
| Relative Strength Index (RSI) | 40.02 |
| Average Volume (20 Days) | 16.03K |
Income Statement
In the last 12 months, Cryo-Cell International had revenue of 31.99M and earned 402.1K in profits. Earnings per share was 0.64.
| Revenue | 31.99M |
| Gross Profit | 24.04M |
| Operating Income | 3.48M |
| Net Income | 402.1K |
| EBITDA | 1.42M |
| EBIT | 3.48M |
| Earnings Per Share (EPS) | 0.64 |
Balance Sheet
The company has 560.96K in cash and 4.45M in debt, giving a net cash position of -3.89M.
| Cash & Cash Equivalents | 560.96K |
| Total Debt | 4.45M |
| Net Cash | -3.89M |
| Retained Earnings | -32.78M |
| Total Assets | 64.68M |
| Working Capital | -9.04M |
Cash Flow
In the last 12 months, operating cash flow was 6.01M and capital expenditures -2.4M, giving a free cash flow of 3.61M.
| Operating Cash Flow | 6.01M |
| Capital Expenditures | -2.4M |
| Free Cash Flow | 3.61M |
| FCF Per Share | 0.44 |
Margins
Gross margin is 75.15%, with operating and profit margins of 10.88% and 1.26%.
| Gross Margin | 75.15% |
| Operating Margin | 10.88% |
| Pretax Margin | 8.77% |
| Profit Margin | 1.26% |
| EBITDA Margin | 4.45% |
| EBIT Margin | 10.88% |
| FCF Margin | 11.28% |
Dividends & Yields
CCEL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 9.88% |
| FCF Yield | 6.88% |
Analyst Forecast
The average price target for CCEL is $8.5, which is 31.2% higher than the current price. The consensus rating is "Buy".
| Price Target | $8.5 |
| Price Target Difference | 31.2% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
Scores
| Altman Z-Score | 0.17 |
| Piotroski F-Score | 9 |